Dr. Husain is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3855 Health Sciences #3011
San Diego, CA 92121Phone+1 858-822-5182- Is this information wrong?
Education & Training
- Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 2009 - 2012
- University of Southern California/LAC+USC Medical CenterResidency, Internal Medicine, 2005 - 2008
- Northwestern University The Feinberg School of MedicineClass of 2005
Certifications & Licensure
- CA State Medical License 2007 - 2025
- MD State Medical License 2009 - 2018
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Nivolumab and Ipilimumab in Combination With Immunogenic Chemotherapy for Patients With Advanced NSCLC Start of enrollment: 2019 Aug 14
- Osimertinib and Abemaciclib in EGFR Mutant Non-Small Cell Lung Cancer After Osimertinib Resistance Start of enrollment: 2020 Nov 21
Publications & Presentations
PubMed
- Adagrasib Treatment After Sotorasib-Related Hepatotoxicity in Patients With-Mutated Non-Small Cell Lung Cancer: A Case Series and Literature Review.Anjali Donnelly, Kevin Lu, Debra Ryan, Jia Luo, Narjust Florez, Yanyan Lou, Patrick C Ma, Alexander I Spira, Hatim Husain> ;JCO Precision Oncology. 2024 Apr 1
- Measurement of ctDNA Tumor Fraction Identifies Informative Negative Liquid Biopsy Results and Informs Value of Tissue Confirmation.Russell W Madison, Lincoln W Pasquina, Derek W Brown, Yanmei Huang, Jason D Hughes, Ryon P Graf, Christian D Rolfo, Geoffrey R Oxnard, Hatim Husain> ;Clinical Cancer Research. 2024 Mar 25
- Osimertinib versus comparator first-generation epidermal growth factor receptor tyrosine kinase inhibitors as first-line treatment in patients with advanced-mutated no...Zhang, D., Liu, X., Shen, F., Zhao, D., Shi, Y., Zhang, H., Liu, J., Gao, X., Chen, M., Zhao, J., Zhong, W., Gao, J., He, M., Liu, Y., Yang, X., Qin, J., Tang, Y., Mu,...> ;Translational Lung Cancer Research. 2023 Nov 30
- Join now to see all
Press Mentions
- Dr. Husain on Liquid Biopsy Versus Tissue Biopsy in NSCLCFebruary 19th, 2020
- TROVAGENE : Other Events (Form 8-K)August 1st, 2015
- Certain Targeted Cancer Drugs Promoting Drug-Resistance, Tumor GrowthMay 7th, 2014
- Join now to see all
Other Languages
- Spanish, Urdu
Hospital Affiliations
- UC San Diego Medical Center - HillcrestSan Diego, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: